Large-scale testing (Phase 3)Study completedNCT04007848What this trial is testingCobimetinib for BRAF-wild-type or Mutated HistiocytosesWho this might be right forDisease or R Group Histiocytoses Assistance Publique - Hôpitaux de Paris 54